186 related articles for article (PubMed ID: 32983140)
1. Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
Märklin M; Fuchs AR; Tandler C; Heitmann JS; Salih HR; Kauer J; Quintanilla-Martinez L; Wirths S; Kopp HG; Müller MR
Front Immunol; 2020; 11():1995. PubMed ID: 32983140
[TBL] [Abstract][Full Text] [Related]
2. NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.
Märklin M; Heitmann JS; Fuchs AR; Truckenmüller FM; Gutknecht M; Bugl S; Saur SJ; Lazarus J; Kohlhofer U; Quintanilla-Martinez L; Rammensee HG; Salih HR; Kopp HG; Haap M; Kirschniak A; Kanz L; Rao A; Wirths S; Müller MR
Nat Commun; 2017 Oct; 8(1):755. PubMed ID: 28970470
[TBL] [Abstract][Full Text] [Related]
3. Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia.
Müller DJ; Wirths S; Fuchs AR; Märklin M; Heitmann JS; Sturm M; Haap M; Kirschniak A; Sasaki Y; Kanz L; Kopp HG; Müller MR
J Leukoc Biol; 2019 Mar; 105(3):531-538. PubMed ID: 30556925
[TBL] [Abstract][Full Text] [Related]
4. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
[TBL] [Abstract][Full Text] [Related]
5. Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome.
Till KJ; Allen JC; Talab F; Lin K; Allsup D; Cawkwell L; Bentley A; Ringshausen I; Duckworth AD; Pettitt AR; Kalakonda N; Slupsky JR
Sci Rep; 2017 Dec; 7(1):16784. PubMed ID: 29196709
[TBL] [Abstract][Full Text] [Related]
6. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
[TBL] [Abstract][Full Text] [Related]
7. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
[TBL] [Abstract][Full Text] [Related]
8. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
Harr MW; Caimi PF; McColl KS; Zhong F; Patel SN; Barr PM; Distelhorst CW
Cell Death Differ; 2010 Sep; 17(9):1381-91. PubMed ID: 20300113
[TBL] [Abstract][Full Text] [Related]
10. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
Tzankov A; Fong D
Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
[TBL] [Abstract][Full Text] [Related]
12. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
13. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
Front Immunol; 2018; 9():1996. PubMed ID: 30271400
[TBL] [Abstract][Full Text] [Related]
14. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
[TBL] [Abstract][Full Text] [Related]
15. Targeting B-cell anergy in chronic lymphocytic leukemia.
Apollonio B; Scielzo C; Bertilaccio MT; Ten Hacken E; Scarfò L; Ranghetti P; Stevenson F; Packham G; Ghia P; Muzio M; Caligaris-Cappio F
Blood; 2013 May; 121(19):3879-88, S1-8. PubMed ID: 23460614
[TBL] [Abstract][Full Text] [Related]
16. A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion.
Yin S; Gambe RG; Sun J; Martinez AZ; Cartun ZJ; Regis FFD; Wan Y; Fan J; Brooks AN; Herman SEM; Ten Hacken E; Taylor-Weiner A; Rassenti LZ; Ghia EM; Kipps TJ; Obeng EA; Cibulskis CL; Neuberg D; Campagna DR; Fleming MD; Ebert BL; Wiestner A; Leshchiner I; DeCaprio JA; Getz G; Reed R; Carrasco RD; Wu CJ; Wang L
Cancer Cell; 2019 Feb; 35(2):283-296.e5. PubMed ID: 30712845
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia.
Fülöp Z; Csernus B; Tímár B; Szepesi A; Matolcsy A
Leukemia; 2003 Feb; 17(2):411-5. PubMed ID: 12592341
[TBL] [Abstract][Full Text] [Related]
18. A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia.
Fuchs AR; Märklin M; Heitmann JS; Futterknecht S; Haap M; Wirths S; Kopp HG; Hinterleitner C; Dörfel D; Müller MR
J Vis Exp; 2018 Dec; (142):. PubMed ID: 30582586
[TBL] [Abstract][Full Text] [Related]
19. Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling.
Theofani E; Alexis S; Costeas P; Andriopoulos C; Feleskoura G; Zikos P; Aktypi A; Spyridonidis A; Nika K
Blood Adv; 2018 Apr; 2(8):877-882. PubMed ID: 29669754
[TBL] [Abstract][Full Text] [Related]
20. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
